MondegarAI
Empery Asset Management, LP

Q1 2022 · 13F-HR

Empery Asset Management, LPholdings as filed

Filed 2022-05-16 · accession 0000902664-22-002947

$21,278
Reported value
77
Positions
2022-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
28252C117POLWQ1847 GOEDEKER INC$5,13524.1%8,295,355CommonSOLE
87807D111TCBWFTC BIOPHARM HOLDINGS PLC$1,3846.50%2,823,528CommonSOLE
30258N121FATBWFAT BRANDS INC$1,2675.95%281,598CommonSOLE
05601U113BRC INC$1,2035.65%269,212CommonSOLE
867781403SUNSHINE BIOPHARMA INC$1,1045.19%450,450CommonSOLE
41150T124HARBOR CUSTOM DEVELOPMENT IN$1,0845.09%2,930,730CommonSOLE
86889P109SURROZEN INC$1,0054.72%333,965CommonSOLE
91914P603THE VALENS COMPANY INC$6883.23%400,000CommonSOLE
53228T119LIGHTNING EMOTORS INC$6633.12%676,381CommonSOLE
G6593L106NISUN INTL ENT DVPMT GP CO L$6583.09%672,556CommonSOLE
67092M125NTRBWNUTRIBAND INC$5812.73%76,604CommonSOLE
405166117HAGERTY INC$5222.45%178,758CommonSOLE
68236X100TOITHE ONCOLOGY INSTITUTE INC$5042.37%70,733CommonSOLE
758338107REEDS INC$4211.98%1,400,000CommonSOLE
86887P119BNCWWCEA INDUSTRIES INC$3351.57%500,000CommonSOLE
834203200SOLENO THERAPETUCS INC$3131.47%1,401,400CommonSOLE
13089P101CALITHERA BIOSCIENCES INC$3131.47%775,925CommonSOLE
G70021111PEPPERLIME HEALTH ACQUSTN CO$3081.45%742,500CommonSOLE
86882L113SURGEPAYS INC$2551.20%286,495CommonSOLE
867781502SBFMWSUNSHINE BIOPHARMA INC$2331.10%235,200CommonSOLE
17248W113CINGWCINGULATE INC$2000.94%500,000CommonSOLE
25461T113DIRECT DIGITAL HOLDINGS INC$1940.91%270,000CommonSOLE
M1R95N118ARBEWARBE ROBOTICS LTD$1870.88%189,904CommonSOLE
98139Q118WORKSPORT LTD$1430.67%193,370CommonSOLE
52886N117LEXXWLEXARIA BIOSCIENCE CORP$1180.55%130,682CommonSOLE
G4236L120GFAIWGUARDFORCE AI CO LTD$1150.54%301,563CommonSOLE
09077D118BFRIWBIOFRONTERA INC$1100.52%75,000CommonSOLE
37518W114GIGINTERNATIONAL1 INC$1080.51%299,999CommonSOLE
03820J100APPLIED GENETIC TECHNOLOGIES$1070.50%100,000CommonSOLE
857561104STABSTATERA BIOPHARMA INC$1050.49%333,016CommonSOLE
M74240116NRSNWNEUROSENSE THERAPEUTICS LTD$960.45%160,000CommonSOLE
M68057112MTEKWMARIS TECH LTD$880.41%297,600CommonSOLE
38071H114GOLD ROYALTY CORP$880.41%112,000CommonSOLE
05072K115AUDDIA INC$880.41%150,000CommonSOLE
23254X110CYCLO THERAPEUTICS INC$870.41%63,036CommonSOLE
Y3894J104IMPERIAL PETE INC$830.39%57,500CommonSOLE
39536G113GREENLIGHT BIOSCIENCES HLDS P$720.34%93,837CommonSOLE
03211Q119AMPGWAMPLITECH GROUP INC$690.32%71,709CommonSOLE
G3302D111FGIWWFGI INDUSTRIES LTD$680.32%102,500CommonSOLE
G1992N126CC NEUBERGER PRINCIPAL HOLDN$680.32%110,014CommonSOLE
716817119PETVWPETVIVO HLDGS INC$640.30%193,290CommonSOLE
00653H110ADARA ACQUISITION CORP$640.30%199,999CommonSOLE
671005114OPY ACQUISITION CORP I$600.28%148,800CommonSOLE
457637502INMED PHARMACEUTICALS INC$580.27%61,741CommonSOLE
74623V111PCTTWPURECYCLE TECHNOLOGIES INC$570.27%20,014CommonSOLE
87251T117TG VENTURE ACQUISITION CORP$490.23%238,428CommonSOLE
098070113BONE BIOLOGICS CORP$480.23%140,471CommonSOLE
623006111MOUNT RAINIER ACQUISITION CORP$480.23%190,764CommonSOLE
496861113KINGSWOOD ACQUISITION CORP$450.21%319,125CommonSOLE
65344E115NXGLWNEXGEL INC$400.19%90,000CommonSOLE
H57830111NLS PHARMACEUTICALS AG$380.18%150,000CommonSOLE
66516W115NORTHERN GENESIS ACQU CORP I$340.16%70,656CommonSOLE
Y71726122PXSAWPYXIS TANKERS INC$340.16%160,000CommonSOLE
50116V115KUBIENT INC$340.16%80,000CommonSOLE
G9127T124TURMERIC ACQUISITION CORP$330.16%99,999CommonSOLE
42238H116BEATWHEARTBEAM INC$330.16%90,000CommonSOLE
380799114GOLDEN ARROW MERGER CORP$310.15%126,665CommonSOLE
41150T116HARBOR CUSTOM DEVELOPMENT IN$300.14%115,814CommonSOLE
75062E106RFLRAFAEL HLDGS INC$300.14%11,983CommonSOLE
76135L119REVBWREVELATION BIOSCIENCES INC$300.14%233,382CommonSOLE
249845116DRMAWDERMATA THERAPEUTICS INC$280.13%175,000CommonSOLE
74760R113QUALTEK SERVICES INC$240.11%41,773CommonSOLE
G5709L117LUMIRADX LIMITED$210.10%23,799CommonSOLE
02919L117AREBWAMERICAN REBEL HOLDINGS INC$210.10%60,240CommonSOLE
92259F119VELODYNE LIDAR INC$200.09%18,968CommonSOLE
539319111LIXTWLIXTE BIOTECHNOLOGY HLDGS IN$200.09%105,263CommonSOLE
81734C114SQLLWSEQLL INC$190.09%235,000CommonSOLE
G1745A124CTSWFCACTUS ACQUISITION CORP I LTD$170.08%100,000CommonSOLE
G4204R117G SQUARED ASCEND I INC$160.08%40,296CommonSOLE
G6780C117ORION BIOTECH OPPORTUNTES CO$150.07%40,000CommonSOLE
18274B114CLASS ACCELERATION CORP$90.04%50,000CommonSOLE
05601A117BOA ACQUISITION CORP$90.04%33,332CommonSOLE
09060U119BIOCARDIA INC$80.04%18,459CommonSOLE
77732R111ROSECLIFF ACQUISITION CORP I$70.03%34,998CommonSOLE
55283P114MDH ACQUISITION CORP$60.03%37,500CommonSOLE
G6546R119NOBLE ROCK ACQUISITION CORP$40.02%15,961CommonSOLE
Q4867H223IMMURON LTD$40.02%46,161CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.